hmmm seems like all we really have going for us now is PTX-100. Omnicar seems to be shelved because a trial is too expensive to run. Sounds like they want to wait until they can find a partner to fund it or until the Biotech sector improves perhaps.
If the FDA don't approve this PTX-100 registration study, this stock is going to sit on the low cents for the foreseeable future. Even if they do approve it, a P2 will take 2-3 years so i have no high hopes for the share price increasing any time soon.
Not a very good short-term outlook unfortunately IMO.
Ann: September 2023 Quarterly Update and Appendix 4C, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
-0.001(2.13%) |
Mkt cap ! $37.04M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.8¢ | 4.4¢ | $180.7K | 3.956M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 259081 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 161692 | 1 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| PTX (ASX) Chart |